Heartland Advisors’s ImmuCell ICCC Stock Holding History

Heartland Advisors’s Portfolio ICCC Stock Details ICCC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-175,000	Closed	-$975K	–	201
2019 Q3	$975K	Sell	175,000 -24,600	-12%	-$144K	0.07%	169
2019 Q2	$1.3M	Hold	199,600	–	–	0.1%	169
2019 Q1	$1.27M	Hold	199,600	–	–	0.09%	167
2018 Q4	$1.41M	Hold	199,600	–	–	0.12%	164
2018 Q3	$1.66M	Hold	199,600	–	–	0.11%	168
2018 Q2	$1.36M	Hold	199,600	–	–	0.09%	171
2018 Q1	$1.4M	Hold	199,600	–	–	0.09%	180
2017 Q4	$1.75M	Sell	199,600 -25,400	-11%	-$208K	0.11%	162
2017 Q3	$1.46M	Hold	225,000	–	–	0.09%	165
2017 Q2	$1.65M	Hold	225,000	–	–	0.11%	164
2017 Q1	$1.24M	Hold	225,000	–	–	0.08%	176
2016 Q4	$1.34M	Hold	225,000	–	–	0.07%	173
2016 Q3	$1.74M	Buy	225,000 +20,028	+10%	+$146K	0.1%	170
2016 Q2	$1.41M	Buy	204,972 +1,872	+0.9%	+$12.6K	0.08%	168
2016 Q1	$1.39M	Buy	+203,100	New	+$1.35M	0.07%	166

Other funds holding ICCC

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Antara Capital New York $30.2K AUM 5.24% 1-Year Est. Return

PCM

Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return

ISL

Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SRC

Shufro Rose & Co New York $1.47B AUM 19.38% 1-Year Est. Return

SFS

Strategic Financial Services Utica, New York $2.1B AUM 19.14% 1-Year Est. Return

HPC

HM Payson & Co Portland, Maine $6.93B AUM 28.92% 1-Year Est. Return

Heartland Advisors's ICCC Position: Q4 2019 in Review

Heartland Advisors sold out of ImmuCell (ICCC) in Q4 2019, closing a stake of 175,000 shares — an estimated $975K sold.

Heartland Advisors first reported a position in ICCC in Q1 2016 and held it in 15 quarters. The position peaked at $1.75M in Q4 2017. 22 funds tracked by Wall St. Rank hold ICCC as of Q4 2019.

Heartland Advisors reported no remaining ImmuCell position as of Q4 2019 after selling out during the quarter.
Heartland Advisors sold 175,000 ImmuCell shares in Q4 2019, an estimated $975K.
Heartland Advisors first reported a position in ImmuCell in Q1 2016 and held it in 15 quarters.
Heartland Advisors's ImmuCell position peaked at $1.75M in Q4 2017.
22 funds tracked by Wall St. Rank held ImmuCell as of Q4 2019.

Based on Heartland Advisors's 13F filing for Q4 2019, filed 11 Feb 2020.